Alan Smith

Alan Smith, Ph.D., has been a leader in cell therapy for more than 30 years. He has held roles spanning research & development, operations, manufacturing, and quality. Before joining Ambys in 2021, he was Chief Technology Officer at Akouos, responsible for technical operations, GMP manufacturing and operations, and quality, among other functions. Earlier, he was Executive Vice President of Technical Operations at Bellicum Pharmaceuticals, responsible for manufacturing, quality control, assay development, process development, facilities, and supply chain. Before Bellicum, Dr. Smith served as the Vice President of Research & Development and Cellular Therapeutics for LifeNet Health and its subsidiary– The Institute of Regenerative Medicine. He was responsible for research, product development, cell production, research tissue, and cardiovascular research for the company, including the Institute’s program management and general operations.

Dr. Smith is a published co-author on numerous journal articles and has held Adjunct Professor appointments at Eastern Virginia Medical School, California State University-Long Beach, and Utah State University. Dr. Smith earned his B.S. degree in Chemistry in 1976 and a Ph.D. degree in Biochemistry in 1982.